Yes, patent infringement control is an issue in China and other places too. Yes, they can copy products, mainly in manufacturing though.
But in RGS' case, this would require creating an entire line of MSCs, extract secretions (which is NOT the patent in question here), and use secretions within a cream (The patent is the use of MSC secretions for skin conditions, not how to develop a MSC line and extract secretions).
So, in this case, I think RGS is fine: their cream using MSC secretions is well protected and the technology not easy to copy.
- Forums
- ASX - By Stock
- CMB
- Ann: Chinese patent granted on stem cell secretions technology
Ann: Chinese patent granted on stem cell secretions technology, page-10
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CMB (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.772M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 1267251 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.6¢ | 746300 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1574 | 0.400 |
1 | 2500 | 0.200 |
1 | 5000 | 0.100 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.545 | 13403 | 1 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
Last trade - 16.12pm 03/07/2024 (20 minute delay) ? |
Featured News
CMB (ASX) Chart |
Day chart unavailable